Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Bacterial Skin and Skin Structure Infection”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Post-approval studies (Phase 4)Study completedNCT03233438
What this trial is testing

Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Bacterial InfectionsAcute Bacterial Skin and Skin Structure Infection
Allergan 91
Testing effectiveness (Phase 2)Study completedNCT01209078
What this trial is testing

GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin Infections, Bacterial
GlaxoSmithKline 84
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Post-approval studies (Phase 4)Study completedNCT02925416
What this trial is testing

Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin Diseases, Bacterial
The Medicines Company 22
Testing effectiveness (Phase 2)Study completedNCT02052388
What this trial is testing

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Who this might be right for
Skin InfectionBacterial Infection
Cellceutix Corporation 215
Not applicableUnknownNCT06072287
What this trial is testing

The Living With a Long-Term Condition Study

Who this might be right for
AsthmaAtrial FibrillationCancer+42 more
King's College London 600
Testing effectiveness (Phase 2)Study completedNCT02426918
What this trial is testing

Study of Debio 1450 for Bacterial Skin Infections

Who this might be right for
Bacterial Infections
Debiopharm International SA 330
Large-scale testing (Phase 3)Study completedNCT01984684
What this trial is testing

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsSkin Structures and Soft Tissue Infections
Melinta Therapeutics, Inc. 850
Testing effectiveness (Phase 2)Study completedNCT00948142
What this trial is testing

Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections

Who this might be right for
Skin Diseases, Bacterial
Arrevus Inc. 198
Large-scale testing (Phase 3)Study completedNCT02066402
What this trial is testing

Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Bacterial Infections
Bayer 598
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15
Testing effectiveness (Phase 2)Study completedNCT03964493
What this trial is testing

TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsGram-Positive Bacterial Infections
TenNor Therapeutics Limited 120
Testing effectiveness (Phase 2)Study completedNCT01593761
What this trial is testing

Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus

Who this might be right for
Skin Infection
CrystalGenomics, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT01119105
What this trial is testing

Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Bacterial InfectionsInfection
Nabriva Therapeutics AG 210
Large-scale testing (Phase 3)Study completedNCT01339091
What this trial is testing

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
AbscessWound InfectionSurgical Site Infection+1 more
Durata Therapeutics Inc., an affiliate of Allergan plc 573
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078357
What this trial is testing

Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor

Who this might be right for
Rheumatic Heart DiseaseRheumatic Heart Disease in ChildrenVaccine Adverse Reaction+3 more
University of Sao Paulo General Hospital 60
Early research (Phase 1)Study completedNCT03873987
What this trial is testing

Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
Melinta Therapeutics, Inc. 102
Large-scale testing (Phase 3)Study completedNCT01252719
What this trial is testing

Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)

Who this might be right for
Wound InfectionAbscessSystemic Inflammation+1 more
Melinta Therapeutics, Inc. 968
Post-approval studies (Phase 4)Ended earlyNCT01734694
What this trial is testing

Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients

Who this might be right for
Health Care Associated PneumoniaOsteomyelitis/Septic ArthritisEndocarditis+2 more
Henry Ford Health System 100
Not applicableLooking for participantsNCT05360914
What this trial is testing

Hospital at Home for Elderly Acute Ill Patients

Who this might be right for
CystitisErysipelasPneumonia
Defactum, Central Denmark Region 849
Load More Results